Skip to main content

Table 2 Details of rapid aCGH results of aneuploid blastocysts derived from 8 patients for fresh SET and 13 patients for vitrified ET

From: A pilot proof-of-principle study to compare fresh and vitrified cycle preimplantation genetic screening by chromosome microarray and next generation sequencing

Case no.

Total no. of aneuploid blastocysts

Single chromosomal abnormality [Single chromosome loss/Single chromosome gain/Single segmental aneuploidy]

Dual chromosomal abnormality

Complex chromosomal abnormality

I. Fresh SET

1

9

4 (44.4 %) [1/2/1]

2 (22.2 %)

3 (33.3 %)

2

5

3 (60.0 %) [1/1/1]

0 (0 %)

2 (40.0 %)

3

11

2 (18.2 %) [1/0/1]

5 (45.5 %)

4 (36.4 %)

4

8

3 (37.5 %) [0/0/3]

1 (12.5 %)

4 (50.0 %)

5

6

4 (66.7 %) [3/0/1]

0 (0 %)

2 (33.3 %)

6

4

2 (50.0 %) [0/0/2]

2 (50.0 %)

0 (0 %)

7

1

1 (100.0 %) [0/0/1]

0 (0 %)

0 (0 %)

8

2

1 (50.0 %) [1/0/0]

0 (0 %)

1 (50.0 %)

Overall

46

20 (43.5 %) [7/3/10]

10 (21.7 %)

16 (34.8 %)

II. Vitrified ET

1

2

1 (50.0 %) [1/0/0]

0 (0 %)

1 (50.0 %)

2

3

2 (66.7 %) [0/0/2]

1 (33.3 %)

0 (0 %)

3

1

1 (100.0 %) [0/0/1]

0 (0 %)

0 (0 %)

4

4

2 (50.0 %) [1/1/0]

1 (25.0 %)

1 (25.0 %)

5

1

1 (100.0 %) [0/1/0]

0 (0 %)

0 (0 %)

6

1

1 (100.0 %) [0/0/1]

0 (0 %)

0 (0 %)

7

1

1 (100.0 %) [0/0/1]

0 (0 %)

0 (0 %)

8

3

2 (66.7 %) [0/0/2]

0 (0 %)

1 (33.3 %)

9

3

1 (33.3 %) [1/0/0]

1 (33.3 %)

1 (33.3 %)

10

0

0 (0 %) [0/0/0]

0 (0 %)

0 (0 %)

11

0

0 (0 %) [0/0/0]

0 (0 %)

0 (0 %)

12

2

1 (50.0 %) [1/0/0]

0 (0 %)

1 (50.0 %)

13

1

0 (0 %) [0/0/0]

0 (0 %)

1 (100.0 %)

Overall

22

13 (59.1 %) [4/2/7]

3 (13.6 %)

6 (27.3 %)